O T C

Dallas, TX, December 2, 2020 – OTC PR WIRE – Alkame Holdings Inc. (OTC PINK: ALKM) and Puration, Inc. (OTC PINK: PURA) today highlighted plans for a recently announced partnership between the two companies.  As part of PURA’s overall hemp lifestyle brand strategy, PURA has acquired a five percent stake in ALKM as part of a strategic partnership.  ALKM already bottles PURA’s EVERx CBD Sports Water and now PURA plans to substantially expand its co packing relationship with ALKM.

In January of this year, PURA launched an acquisition campaign as a forerunner initiative to the first step of its hemp lifestyle brand transition. The company leveraged its own experience and organic core competencies to acquire CBD infused beverage, edible and topical businesses.

PURA targeted CBD product acquisitions that could be enhanced with PURA’s patented technology. PURA owns a license to a U.S. Patented cannabis extraction process backed by extensive university medical research. The license, issued by NCM Biotech, is exclusive for beverages, edibles and cosmetics among other uses. NCM Biotech is focused on medical research and Puration has access to that research.

Since launching the acquisition campaign in January, the company has acquired a CBD confections business, a CBD pet products business and CBD sun care business.  Combined with its existing beverage industry product line, PURA’s combined horizontal market opportunity ranges across over $2 trillion in market value:

Sexual wellness                      $39 Billion Projected Market Value  

Confections                             $232 Billion Projected Market Value 

Pet Products                           $202 Billion Projected Market Value 

Sun Care                                 $12.6 Billion Projected Market Value  

Non-Alcoholic Beverage         $1.6 Trillion Projected Market Value 

Look for a series of updates coming soon on new PURA products to be produced by ALKM.

 

For more information on Puration, visit http://www.purationinc.com

About West Coast Co Packer, Inc.
West Coast Co Packer, Inc., is a wholly owned subsidiary of Alkame Holdings, Inc. and is a specialty liquid and single-serve manufacturer, co-packer, private labeler, and contract manufacturer.

 

 

About Alkame Holdings, Inc.
Alkame Holdings, Inc. is a publicly traded health and wellness technology holding company with a focus on patentable, innovative, and eco-friendly consumer products. The Company’s wholly owned subsidiaries manufacture products with enhanced water utilizing proprietary technology to create products with several unique properties. The organization is diligently building a strong foundation through the launch and acquisition of appropriate business assets, and by pursuing multiple applications and placement into several emerging business sectors including but not limited to the following: consumer bottled water, RTD products, liquid hemp-based products, household pet products, horticulture, agriculture, and medical applications, including hand sanitizers, and many other various water-based treatment solutions to both new and existing business platforms.

For more information, visit www.alkameholdingsinc.com.

CONTACT:
Alkame Holdings, Inc. Investor Relations
Website: www.alkameholdingsinc.com
Email: info@alkameholdingsinc.com

Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350

Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company’s contracts, the Company’s liquidity position, the Company’s ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

SOURCE: Alkame Holdings, Inc.

 

 

 

Related Post

No Comments

Leave a Comment

Recent Posts

Recent Posts

Contact Us

All Rights Reserved © 2019